Our study showed that pre-endoscopic serum albumin level, intrahepatic biliary obstruction, stage IV cancer, improvement of hyperbilirubinemia within 2 weeks after stenting, and receiving chemotherapy were independent risk factors for 90-day mortality in patients with pancreaticobiliary cancers. The gene discussed is ALB; the disease is Hyperbilirubinemia.